Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Canadian Lung Association Research Fellowship

University of British Columbia

$40,000.00

Utilizing optical coherence tomography and exercise to develop novel biomarkers of respiratory impairment in people living with human immunodeficiency virus

EF 2022-23

Résumé
The high-resolution imaging technique used in this study has not been used to study airway health in people with HIV before. It will provide pictures of airway damage that cannot be seen by our current diagnostic tools. We can use these pictures to diagnose patients with lung disease far earlier. People with human immunodeficiency virus (HIV) experience breathing discomfort that is worse than would be expected based on the results from their lung function tests. The cause of this breathing discomfort is unknown. Identifying new markers of lung health, or biomarkers, that are more sensitive to detecting airway damage than lung function tests would help doctors make treatment decisions and improve the quality of life in people with HIV. We will develop imaging and exercise biomarkers to capture early airway damage in people with HIV. Ten females and males between 40-60 years old with HIV and ten sex- and age-matched controls without HIV will be recruited for this study. Participants will undergo lung function testing, take a questionnaire to determine how breathing discomfort affects their life, undergo a bronchoscopy procedure, and perform an exercise test. Bronchoscopy is a commonly performed medical procedure that involves putting a flexible, thin (size of a pencil) tube called a bronchoscope into the airways through the mouth. The bronchoscopy procedure will be combined with an imaging technique called optical coherence tomography (OCT). OCT uses a very small camera (0.9 mm) to collect extremely detailed airway images (details as small as 0.01 mm can be seen). Airway images will be compared between people with HIV and controls to find different image features between the groups that can be used as biomarkers for airway damage in HIV. The exercise test will be performed on a stationary bike and several responses (e.g., breathing and heart rate) will be measured. Differences in the exercise responses between groups will help identify exercise biomarkers of airway damage in HIV. Identifying new imaging and exercise biomarkers of airway damage in people living with HIV will allow for early diagnosis and treatment and improve lung health for this population. Chronic obstructive pulmonary disease (COPD), a group of diseases that block airflow in the lungs and cause breathing problems, is more common and diagnosed earlier in people with HIV compared to those without HIV. Detection of early airway damage with the biomarkers developed in the proposed work may allow researchers to slow or stop the progression of airway damage in people with HIV before COPD develops.
Programme
Canadian Lung Association Research Fellowship
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
477100
Name
Peters Carli
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Canadian Lung Association (Ottawa)
Prcname2
Special Cases
Projecttitle
Utilizing optical coherence tomography and exercise to develop novel biomarkers of respiratory impairment in people living with human immunodeficiency virus
Programtype2
Salary Programs
Orgnameinp2
University of British Columbia
Cihramount2
$40,000
Cihrequipment2
$0
Programname2
Canadian Lung Association Research Fellowship
Keyworddelim
Chronic Obstructive Pulmonary Disease; Early Detection; Exercise; Human Immunodeficiency Virus; Imaging
Abstract
The high-resolution imaging technique used in this study has not been used to study airway health in people with HIV before. It will provide pictures of airway damage that cannot be seen by our current diagnostic tools. We can use these pictures to diagnose patients with lung disease far earlier. People with human immunodeficiency virus (HIV) experience breathing discomfort that is worse than would be expected based on the results from their lung function tests. The cause of this breathing discomfort is unknown. Identifying new markers of lung health, or biomarkers, that are more sensitive to detecting airway damage than lung function tests would help doctors make treatment decisions and improve the quality of life in people with HIV. We will develop imaging and exercise biomarkers to capture early airway damage in people with HIV. Ten females and males between 40-60 years old with HIV and ten sex- and age-matched controls without HIV will be recruited for this study. Participants will undergo lung function testing, take a questionnaire to determine how breathing discomfort affects their life, undergo a bronchoscopy procedure, and perform an exercise test. Bronchoscopy is a commonly performed medical procedure that involves putting a flexible, thin (size of a pencil) tube called a bronchoscope into the airways through the mouth. The bronchoscopy procedure will be combined with an imaging technique called optical coherence tomography (OCT). OCT uses a very small camera (0.9 mm) to collect extremely detailed airway images (details as small as 0.01 mm can be seen). Airway images will be compared between people with HIV and controls to find different image features between the groups that can be used as biomarkers for airway damage in HIV. The exercise test will be performed on a stationary bike and several responses (e.g., breathing and heart rate) will be measured. Differences in the exercise responses between groups will help identify exercise biomarkers of airway damage in HIV. Identifying new imaging and exercise biomarkers of airway damage in people living with HIV will allow for early diagnosis and treatment and improve lung health for this population. Chronic obstructive pulmonary disease (COPD), a group of diseases that block airflow in the lungs and cause breathing problems, is more common and diagnosed earlier in people with HIV compared to those without HIV. Detection of early airway damage with the biomarkers developed in the proposed work may allow researchers to slow or stop the progression of airway damage in people with HIV before COPD develops.
Competitiondate
202210
Approvedterm2
1 yr 0 mth
Pinamesdelim
Peters, Carli
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Circ &Respiratory Hlth~ $40,000~ $0~